These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2884554)

  • 21. Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis.
    Pacca SR; de Azevedo AP; De Oliveira CF; De Luca IM; De Nucci G; Antunes E
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):201-7. PubMed ID: 11791005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic use of beta blockers in gastroenterology. Gastrointestinal iatrogenic diseases caused by beta blocker use].
    De Simone M; Leonardi C; Carbonetti M; Mazzetti di Pietralata M
    Minerva Dietol Gastroenterol; 1985; 31(2):245-52. PubMed ID: 2863787
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacotherapy of Raynaud's phenomenon.
    Belch JJ; Ho M
    Drugs; 1996 Nov; 52(5):682-95. PubMed ID: 9118818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cold-induced potentiation of alpha 2-adrenergic vasoconstriction in primary Raynaud's disease.
    Freedman RR; Moten M; Migály P; Mayes M
    Arthritis Rheum; 1993 May; 36(5):685-90. PubMed ID: 8387786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [My hypertensive patient wants beta blockers. Are they not obsolete?].
    Stawowy P
    MMW Fortschr Med; 2014 Aug; 156(14):17. PubMed ID: 25195387
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of two beta-blocking drugs in patients with Raynaud's phenomenon.
    Holti G
    Practitioner; 1982 Apr; 226(1366):781-3. PubMed ID: 7045853
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevalence of Raynaud's phenomenon in patients with migraine.
    Zahavi I; Chagnac A; Hering R; Davidovich S; Kuritzky A
    Arch Intern Med; 1984 Apr; 144(4):742-4. PubMed ID: 6143540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study.
    Ábarzúa-Araya A; Navarrete-Dechent CP; Heusser F; Retamal J; Zegpi-Trueba MS
    J Am Acad Dermatol; 2014 Jun; 70(6):1045-9. PubMed ID: 24656727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apparent finger systolic pressures during cooling in patients with Raynaud's syndrome.
    Carter SA; Dean E; Kroeger EA
    Circulation; 1988 May; 77(5):988-96. PubMed ID: 3359596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-adrenoceptor activity and resting energy metabolism in weight losing cancer patients.
    Hyltander A; Daneryd P; Sandström R; Körner U; Lundholm K
    Eur J Cancer; 2000 Feb; 36(3):330-4. PubMed ID: 10708933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered regulator mechanisms of presynaptic adrenergic nerve: a new physiopathological hypothesis in Raynaud's disease.
    Giovanni B; Giuseppina CM; Susanna F; Roberto M
    Microvasc Res; 1984 Jan; 27(1):110-3. PubMed ID: 6323930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double blind randomised placebo controlled trial of hexopal in primary Raynaud's disease.
    Sunderland GT; Belch JJ; Sturrock RD; Forbes CD; McKay AJ
    Clin Rheumatol; 1988 Mar; 7(1):46-9. PubMed ID: 3044673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta blockers and quality of life.
    Cruikshank JM; McAinsh J
    Br J Clin Pract; 1992; 46(1):34-8. PubMed ID: 1358162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Objective relief of vasospasm by glyceryl trinitrate in secondary Raynaud's phenomenon.
    Coppock JS; Hardman JM; Bacon PA; Woods KL; Kendall MJ
    Postgrad Med J; 1986 Jan; 62(723):15-8. PubMed ID: 3099273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: randomized crossover trial.
    Punda A; Polić S; Rumboldt Z; Bagatin J; Marković V; Lukin A
    Croat Med J; 2005 Apr; 46(2):219-24. PubMed ID: 15849842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atenolol Versus Propranolol for Treatment of Infantile Hemangiomas During the Proliferative Phase: A Retrospective Noninferiority Study.
    Bayart CB; Tamburro JE; Vidimos AT; Wang L; Golden AB
    Pediatr Dermatol; 2017 Jul; 34(4):413-421. PubMed ID: 28556385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. β-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort.
    Hicks BM; Murray LJ; Powe DG; Hughes CM; Cardwell CR
    Ann Oncol; 2013 Dec; 24(12):3100-6. PubMed ID: 24050955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Raynaud's phenomenon with calcium channel blockers.
    Smith CR; Rodeheffer RJ
    Am J Med; 1985 Feb; 78(2B):39-42. PubMed ID: 3976694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and treatment of Raynaud's phenomenon].
    Guilmot JL; Diot E; Lasfargues G
    Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1755-60. PubMed ID: 1685081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Managing Raynaud's phenomenon: a practical approach.
    Adee AC
    Am Fam Physician; 1993 Mar; 47(4):823-9. PubMed ID: 8438681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.